NYSE Euronext : Zoetis? Celebrates Initial Public Offering and First Day of Trading on the New York Stock Exchange

0

02/01/2013 | 06:10pm CET

Send by mail :

Last Name :

Name :

From* :

To* :

(You can enter multiple email addresses separated by commas)

Message :

*Required fields

Zoetis, a leading animal health company, opened for trading today on the
New York Stock Exchange (NYSE) under the ticker symbol "ZTS"
after its initial public offering. Barclays is the Designated Market
Maker (DMM) for the company's stock. CEO Juan Ramón Alaix, joined by
members of the Zoetis team, celebrated the company's first day of
trading by visiting the NYSE trading floor for the stock opening and by
ringing The Opening Bell.

Zoetis Chief Executive Officer Juan Ramon Alaix, joined by members of the Zoetis team, rings the NYSE Opening Bell to celebrate the company's IPO and first day of trading on the NYSE. (Source: NYSE Euronext Photo)

"We welcome Zoetis to our growing community of listed companies," said
Scott Cutler, Executive Vice President, Head of Global Listings, NYSE
Euronext. "As the largest standalone company in animal health, Zoetis
supports veterinarians and livestock producers around the world with
innovative medicines and vaccines that help them raise and care for
animals. We congratulate Zoetis as they embark upon this new chapter and
look forward to a long-standing partnership with the company and its
shareholders."

For more information on NYSE Euronext's Listings business and to learn
about trends in the IPO market, please visit the NYSE
Euronext IPO Center.

About Zoetis (NYSE: ZTS)

Zoetis (z?-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
with a focus on both farm and companion animals. The company generated
annual revenue of $4.2 billion in fiscal 2011. Zoetis has more than
9,500 employees and a local presence in approximately 70 countries,
including 29 manufacturing facilities in 11 countries. Its products
serve veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries. (Source: Zoetis)

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets
and provider of innovative trading technologies. The company's exchanges
in Europe and the United States trade equities, futures, options,
fixed-income and exchange-traded products. With approximately 8,000
listed issues (excluding European Structured Products), NYSE Euronext's
equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT,
NYSE Alternext and NYSE Arca - represent one-third of the world's
equities trading, the most liquidity of any global exchange group. NYSE
Euronext also operates NYSE Liffe, one of the leading European
derivatives businesses and the world's second-largest derivatives
business by value of trading. The company offers comprehensive
commercial technology, connectivity and market data products and
services through NYSE Technologies. NYSE Euronext is in the S&P 500
index. For more information, please visit: http://www.nyx.com.